Skip to Main Navigation

COVID-19 Response Project

Abstract*

The proposed Project would be implemented over a period of two years under the Fast-track CCOVID-19 Facility (FTCF) for a total amount of US$20 million and is organized into three components as presented below. Component 1. Improving COVID-19 Prevention, Detection and Emergency Response; Subcomponent 1.1: Strengthening surveillance and rapid response to suspected cases of COVID-19 Subcomponent 1.2: Strengthening risk communication and community...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The Program Development Objective is to prevent, detect, and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Turkmenistan.

Key Details

Project Details

  • P175131

  • Closed

  • Oraz Sultanov , Shuo Zhang

  • Ministry of Finance and Economy of Turkmenistan

  • Turkmenistan

  • December 24, 2020

  • (as of board presentation)

    June 30, 2021

  • September 23, 2021

  • US$ 20.00 million

  • Ministry of Health and Medical Industry of Turkmenistan

  • Europe and Central Asia

  • 2021

  • US$ 20.00 million

  • N/A

  • March 28, 2024

  • December 31, 2023

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
International Bank for Reconstruction and Development 20.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 20.00
IDA Commitment N/A
IBRD + IDA Commitment 20.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 20.00

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Jun 30, 2021 IBRD-92850 Loan Commitment 20,000,000.00
Sep 23, 2021 IBRD-92850 Fee Charges 50,000.00
Apr 15, 2024 IBRD-92850 Int Charges 650,153.06
May 9, 2023 IBRD-92850 Loan Disb 8,008,143.00
Oct 15, 2023 IBRD-92850 Int Charges 10,295.05
Oct 15, 2023 IBRD-92850 Int Charges 597,509.25
Apr 15, 2023 IBRD-92850 Int Charges 443,754.50
Apr 15, 2023 IBRD-92850 Int Charges 2,292.00
Apr 15, 2023 IBRD-92850 Int Charges 15,346.92
May 9, 2023 IBRD-92850 Loan Disb -8,008,143.00
Dec 21, 2022 IBRD-92850 Loan Disb 4,994,519.00
Oct 15, 2022 IBRD-92850 Int Charges 198,824.40
Oct 15, 2022 IBRD-92850 Int Charges 6,260.25
Apr 15, 2022 IBRD-92850 Int Charges 9,606.41
Apr 15, 2022 IBRD-92850 Int Charges 49,099.99
Apr 15, 2022 IBRD-92850 Int Charges 2,869.52
Apr 15, 2022 IBRD-92850 Int Charges 23.84
Nov 17, 2021 IBRD-92850 Loan Disb 14,955,481.00
Sep 23, 2021 IBRD-92850 Loan Disb 50,000.00
Apr 15, 2024 IBRD-92850 Int Charges 6,885.66

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Project Management Satisfactory 2024-04-17
Overall Implementation Progress (IP) Highly Satisfactory 2024-04-17
Procurement Satisfactory 2024-04-17
Progress towards achievement of PDO Highly Satisfactory 2024-04-17
Financial Management Satisfactory 2024-04-17
Monitoring and Evaluation Satisfactory 2024-04-17

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • PDO Indicator 3: Number of designated beds for COVID-19 patients with access to continuous oxygen supplyValue0.001000.00600.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • PDO Indicator 1: Development and periodic update of a comprehensive national COVID-19 risk communication plan, including standardized, evidence-based information targeted to different population groupValueNo comprehensive national COVID-19 risk communicatThe comprehensive national COVID-19 risk communicaA comprehensive national COVID-19 risk communicati
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • PDO Indicator 2: Number of COVID-19 designated laboratories with verified diagnostic equipment and test kits.Value0.0018.005.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • PDO Indicator 4: A National Pandemic Preparedness and Response Plan is regularly updated and tailored for each region.ValueA national Pandemic Preparedness and Response PlanThe National Pandemic Preparedness and Response PlThe National Pandemic Preparedness and Response Pl
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of health staff (physicians and nurses) trained in infection prevention and control in accordance with approved protocolsValue0.004001.004000.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Clinical protocols, including a referral system, to care for COVID-19 patients are regularly reviewed or updatedValueClinical protocols, including a referral system, fNew Clinical protocols were approved. Seminars andClinical protocols, including a referral system, f
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Number of hospital and primary care physicians trained in the management of COVID-19 and SARI patients and adherence to COVID-19 protocolsValue0.002164.002000.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Number of COVID-19 designated laboratories with staff trained to conduct COVID-19 diagnosisValue0.0018.0013.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • List of equipment, consumables and medications for resuscitation and management of COVID-19 and SARI patients with lung function disorders is defined and regularly updated.ValueNo verified list of equipment, consumables and medA verified list of equipment, consumables and mediA verified list of equipment, consumables and medi
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Electronic program for tracking and monitoring contacts developed and set up in Sanitary and Epidemiological Safety and Control (SESC) offices in Ashgabat and in five velayatsValueNo electronic program for tracking and monitoring Installed and available on the state telecom compaAn electronic program for tracking and monitoring
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Number of focus groups conducted to engage communities, understand their needs and receive feedback on the projectValue0.0016.0016.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Number of risk communication messages targeted to different population groups developedValue0.004.004.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Number of gender-specific information campaigns delivered.Value0.002.002.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Percentage of participants in community meetings/events reporting that the local outreach and community engagement process is effective (disaggregated by gender)Value0.0075.0075.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Number of public health specialists trained on climate-induced vector borne diseases and waterborne diseasesValue0.00103.00100.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Percentage increase in risk awareness of COVID-19 among PHC nursesValue0.00100.0050.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment
  • Hospital preparedness plans on COVID-19 are prepared in 5 infectious disease hospitals in 5 districts and health workers trainedValue0.005.005.00
    DateJanuary 29, 2021March 22, 2024December 31, 2023
    Comment